Incyte

Incyte is a global biopharmaceutical enterprise that discovers, develops, and commercializes novel therapeutics for oncology, hematology, and inflammatory diseases. The company is celebrated for developing Jakafi, a pioneering JAK inhibitor used in treating myelofibrosis and polycythemia vera, alongside its topical formulation Opzelura for vitiligo and atopic dermatitis. Through targeted small-molecule discovery and antibody therapeutics, Incyte addresses substantial unmet medical needs worldwide.